Skinuva Achievements Timeline

  • Skinuva® Scar
  • Skinuva® Brite

December 2016

  • Completed final formulation for Skinuva® Scar.

January 2017

  • Initiated Study Arm 1—Safety and Efficacy of Skinuva® Scar Cream.
  • Patent Pending.

February 2017

  • Dermatologic Tested.

March 2017

  • Trademark granted for Skinuva®

April 2017

  • Study Arm 1 concluded and showed incredibly positive results.

May 2017

  • Passed compliance for various tests for establish safety and stability of Skinuva® Scar.
  • Initiated Study Arm 2—Double Blinded, Randomized Multicenter Study to evaluate Skinuva®Scar vs Silicone Cream.

September 2017

  • Study Arm 2 ended enrollment.
  • Initiated Study Arm 1-Safety and Efficacy of Skinuva® Stretch Mark Cream.

November 2017

  • Initiated Study Arm 1-Safety and Efficacy of Skinuva® Acne Serum.

December 2017

  • Topical Scar Cream Review Article accepted for publication, in press.
  • Study Arm 2 was concluded, nearly 50 patients were enrolled.

January 2018

  • Production of Skinuva® Scar.
  • Submission of Skinuva® Scar clinical data article.

February 2018

  • Formal launching of Skinuva® Scar at American Academy of Dermatology, San Diego.

March 2018

August 2018

November 2019

  • Skinuva® receives full patent for its next generation scar cream formula.

March 2019

  • Completed final formulation for Skinuva® Brite.

May 2019

  • Initiated Study Arm 1—Safety and Efficacy of Skinuva® Brite Cream.

June 2019

  • Dermatologic Tested.

July 2019

  • Study Arm 1 concluded and showed safety and high efficacy profile.

August 2019

  • Passed compliance for various tests for establish safety and stability of Skinuva® Brite.

September 2019

  • Initiated Study Arm 2—Skinuva® Brite vs. hydroquinone 4%: head to head trial.

November 2019

  • Study Arm 2 ended enrollment.

January 2020

  • Submission of Journal publication: Skinuva® Brite vs. hydroquinone 4%: head to head trial.

February 2020

  • Production of Skinuva® Brite.

March 2020

  • Launch of Skinuva® Brite.